NCT01907776View on ClinicalTrials.gov

Pharmacokinetics and Safety Study of ME1100 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2013

Conditions
Healthy
Interventions
DRUG

ME1100 inhalation solution

ME1100 inhalation solution (arbekacin for oral inhalation at 150mg/mL), 0.6, 2.0, 3.0, 4.0, 6.0, or 9.0mL, Single Dose

DRUG

ME1100 placebo inhalation solution

Vehicle placebo

Trial Locations (1)

Unknown

WCCT Global, LLC, Cypress

Sponsors
All Listed Sponsors
lead

Meiji Seika Pharma Co., Ltd.

INDUSTRY

NCT01907776 - Pharmacokinetics and Safety Study of ME1100 in Healthy Volunteers | Biotech Hunter | Biotech Hunter